1[1]Pasteau O, Degrais P, De L'emploi du radium dans le traitement des cancers de la prostate. J Urol, Med Chir, 1913,4:341-366
2[2]Flocks RH, Kerr HD, Elkins HB, et al. Treatment of carcinoma of the prostate by interstitial radiation with radioactive gold-198: a preliminary report. J Urol, 1952,68: 510-522.
3[3]Holm HH, Gammelgaard J, Ultrasonically guided precise needle placement in the prostate and seminal vesicles. J Urol, 1981,125:385-387.
4[4]Kaplan ID, Holupka EJ, Meskell P, et al. Intraoperative treatment planning for radioactive seed implant therapy for prostate cancer. Urology, 2000 56:492-495.
5[5]Sharkey J, Chovnick SD, Behar R J, et al. Evolution of techniques for ultrasound-guided palladium 103 brachytherapy in 950 patients with prostate cancer. Tech Urol, 2000, 6:128-134.
6[6]Dicker AP, Lin CC, Leeper DB, et al. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 1251 based on radiobiological effectiveness and dosimetry. Semin Urol Oncol, 2000, 18:152-159.
7[7]Martin T, Hey-Koch S, Strassmann G , et al. 3D interstitial HDR brachytherapy combined with 3D external beam radiotherapy and androgen deprivation for prostate cancer. Preliminary results. Strahlenther Onkol, 2000, 176:361-367.
8[8]Nag S Brachytherapy for prostate cancer: summary of American Brachytherapy Society recommendations. Semin Urol Oncol,2000,18:133-136.
9[9]Stone NN, Stock RG, Prostate brachytherapy in patients with prostate volumes ＞/= 50 cm(3 ]: dosimetic analysis of implant guality. Int J Radiat Oncol Biol Phys, 2000 , 46:1199-1204.
10[10]Wang H, Wallner K, Sutlief S, et al. Transperineal brachytherapy in patients with large prostate glands. Int J Cancer, 2000,90:199-205.
